Carregant...
Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy
Prevalence of anxiety or depression was investigated in 105 coronavirus disease 2019 (COVID‐19) patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale (HADS‐A/D). 30% of patients displayed pathological HADS‐A/D, 52.4% showed persistent symptoms. Pathological pa...
Guardat en:
| Publicat a: | J Med Virol |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7461061/ https://ncbi.nlm.nih.gov/pubmed/32841387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26459 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|